Drug delivery

Cytel, provider of statistical software and advanced analytics for clinical trial design and execution, has launched East Bayes, an web-based extension of the East platform that enables adoption of the most computationally intensive Bayesian clinical trial designs, without the need for powerful on-site computers. The launch expands East’s range of Bayesian trial designs by providing […]

‍IRICoR, a pan-Canadian drug discovery and research commercialisation centre, Université de Montréal (UdeM), the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Valence Discovery, AI-enabled drug designer, have announced a collaboration focussing on the discovery of novel drug candidates for the treatment of levodopa-induced dyskinesia in Parkinson’s disease. Parkinson’s disease […]

Global biopharmaceutical company Amryt has signed a distribution agreement with Medison Pharma Canada to distribute Myalepta (metreleptin) in Canada. Amryt is a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising novel treatments for rare diseases. Medison is a commercial partner of global biotech companies that provide integrated services for biotech companies looking to […]

UK reagents and therapeutics developer, Aptamer Group has extended its current agreement with global biopharmaceutical company AstraZeneca. This agreement will build upon the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates. Optimers are optimised aptamer reagents. Based […]

Novaratis has signed an initial agreement to manufacture biopharmaceutical company CureVac’s COVID-19 vaccine candidate, CVnCoV. Following final agreement, Novartis plans to start manufacturing of the mRNA and bulk drug product in the second quarter of 2021. It is anticipated to produce up to 50 million doses by the end of 2021 and a further 200 […]

Inspired by a parasitic worm that digs its sharp teeth into its host’s intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body. David Gracias, a professor in the Johns Hopkins University Whiting School of Engineering, and Johns Hopkins gastroenterologist Florin Selaru, Director of […]